66 related articles for article (PubMed ID: 16198400)
41. Prevention of cervical cancer in resource-poor settings.
Walraven G
Lancet; 2003 Jun; 361(9375):2160; author reply 2160-1. PubMed ID: 12826462
[No Abstract] [Full Text] [Related]
42. Nicaragua: an example of commitments and strengths despite problems of poverty.
Ross CA
J Prof Nurs; 2007; 23(6):e9-12. PubMed ID: 18053955
[TBL] [Abstract][Full Text] [Related]
43. Cervical cancer screening: high coverage or high quality?
Bischof U; Chingang LC; Razum O
Trop Med Int Health; 2003 Jun; 8(6):579. PubMed ID: 12791065
[No Abstract] [Full Text] [Related]
44. Feasibility and Acceptability of Tele-Colposcopy on the Caribbean Coast of Nicaragua: A Descriptive Mixed-Methods Study.
Mitchell EM; Doede AL; McLean Estrada M; Granera OB; Maldonado F; Dunn B; Banks S; Marks-Symeonides I; Morrone D; Pitt C; Dillingham RA
Telemed Rep; 2021; 2(1):264-272. PubMed ID: 35720751
[No Abstract] [Full Text] [Related]
45. [Evolution of pediatrics in Nicaragua under the Ministry of Public Health].
CASTILLO G
Nicar Med; 1963; 19():7-10. PubMed ID: 14019241
[No Abstract] [Full Text] [Related]
46. [Pan American Hospital Questionnaire; Nicaragua; 1945].
Bol Oficina Sanit Panam; 1947 Mar; 26(3):242. PubMed ID: 20256612
[No Abstract] [Full Text] [Related]
47. Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review.
Dykens JA; Smith JS; Demment M; Marshall E; Schuh T; Peters K; Irwin T; McIntosh S; Sy A; Dye T
Cancer Causes Control; 2020 May; 31(5):417-429. PubMed ID: 32185604
[TBL] [Abstract][Full Text] [Related]
48. Knowledge and beliefs regarding cervical cancer screening and HPV vaccination among urban and rural women in León, Nicaragua.
Rees HD; Lombardo AR; Tangoren CG; Meyers SJ; Muppala VR; Niccolai LM
PeerJ; 2017; 5():e3871. PubMed ID: 29085745
[TBL] [Abstract][Full Text] [Related]
49. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
50. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
Suba EJ
Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer prevention in remote rural Nicaragua: a program evaluation.
Howe SL; Vargas DE; Granada D; Smith JK
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S232-5. PubMed ID: 16198400
[TBL] [Abstract][Full Text] [Related]
52. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
53. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
Couzos S; Wronski I; Murray R; Cox H
Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
55. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
